| 发明名称 |
NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) |
| 摘要 |
The present invention relates to a pharmaceutical product comprising a) as a first component an inhibitor of the MDM2-p53 interaction; and b) as a second component cytarabine; as a combined preparation for the sequential or simultaneous use in the treatment of cancer, particularly AML. |
| 申请公布号 |
PH12016500933(A1) |
申请公布日期 |
2016.06.27 |
| 申请号 |
PH12016500933 |
申请日期 |
2016.05.19 |
| 申请人 |
F.HOFFMAN-LA ROCHE AG |
发明人 |
HIGGINS, BRIAN;PACKMAN, KATHRYN E;NICHOLS, GWEN |
| 分类号 |
A61K31/40;A61K31/7068;A61K31/77;A61K45/06;A61P35/00;A61P35/02 |
主分类号 |
A61K31/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
